- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, "To allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.", regarding all provisions - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021", regarding all provisions - S 3799 - "PREVENT Pandemics Act", regarding all provisions - HR 3932/S 2076 - "PASTEUR Act of 2021", regarding all provisions - HR 5376 - "Inflation Reduction Act", regarding provisions on drug pricing and provisions related to revenue - HR 7559 - Prescription Information Modernization Act of 2022, regarding all provisions - HR 2617 - "Consolidated Appropriations Act, 2023", regarding provisions related to pharmaceuticals, medical devices, mental health, and tax - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation
Lobbyistsmrs DARREL C JODREY · mrs JANE MARGARET ADAMS · DAVID KAVANAUGH · KELLY WATERS · LEIF BRIERLEY · LARRY CAMM · RILEY SWINEHART · ABIGAIL PINKELE · DEANA MCRAE · ROBERTO SADA · AMY PELLEGRINO · WENDY SUSSMAN · mrs MEGHAN DRENAN STONE · TIMOTHY SWOPE · COLLEEN VIVALDI · EMELY SANCHEZ
Covered position (EMELY SANCHEZ): Intern, HHS OIG: Spring 2016, Intern, CDC CSTLTS: Fall 2017 and Summer 2020, Intern, Rep. Donna Shalala Fall 2019, Intern Senate HELP Committee: Fall 2020
Consumer Issues/Safety/Products
- HR 2116, "Creating a Respectful and Open World for Natural Hair (CROWN ACT)", regarding all provisions - S 936, "INFORM Consumers Act", regarding all provisions - HR 3429/S 1843, "SHOP SAFE Act", regarding all provisions - S 3416, "Protecting Patients from Counterfeit Medical Devices Act", regarding the expansion of the enforcement authority of the FDA with respect to counterfeit devices - HR 6207/S 3357, "Humane Cosmetics Act", regarding all provisions - Issues related to ingredient safety - Issues related to animal testing and consumer products - Issues related to counterfeit consumer products - Issues related to brand protection - Issues related to e-Commerce
Lobbyistsmrs DARREL C JODREY · LEIF BRIERLEY · ROBERTO SADA
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
- HR 5214, "To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements.", regarding expenditures from HSAs, FSAs, and health reimbursement arrangements for dietary supplements - Issues related to Health Spending Accounts & Flexible Spending Accounts - Issues related to corporate tax provisions of reconciliation bill - U.S. Treasury policy and negotiating positions related to tax at the Organisation for Economic Co-operation and Development ("OECD") - Issues related to US Treasury implementation of new corporate alternative minimum tax - Issues related to WTO TRIPS agreement
Lobbyistsmrs DARREL C JODREY · mrs JANE MARGARET ADAMS · DAVID KAVANAUGH · ABIGAIL PINKELE · WENDY SUSSMAN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Trade (domestic/foreign)
- HR 2884/S 1435, Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act, regarding all provisions - Issues related to mandatory supply chain requirements, including under "Buy America" - Issues related to waiver of WTO TRIPS related to COVID response
LobbyistsDAVID KAVANAUGH · TIMOTHY SWOPE
TargetedSENATE · HOUSE OF REPRESENTATIVES
